 |
Previous Article | Next Article 
The Journal of Neuroscience, April 1, 1998, 18(7):2740-2747
Facilitative Effects of the Ampakine CX516 on Short-Term
Memory in Rats: Enhancement of Delayed-Nonmatch-to-Sample
Performance
Robert E.
Hampson1,
Gary
Rogers2,
Gary
Lynch3, and
Sam A.
Deadwyler1
1 Department of Physiology and Pharmacology, Wake
Forest University School of Medicine, Winston Salem, North Carolina
27157, 2 Cortex Pharmaceuticals, Irvine, California 92718, and 3 Department of Psychiatry, University of California,
Irvine, California 92715
Ampakines are a family of drugs that selectively increase AMPA
receptor-gated currents and improve performance on several behavioral
tasks. This report describes evidence that ampakines cause a
cumulative enhancement of performance in a spatial short-term memory
task (). Two groups of rats were trained on a
spatial variant of the delayed-nonmatch-to-sample (DNMS) paradigm. One
group (n = 12) received the ampakine CX516 (Cortex
Pharmaceuticals) alternated with vehicle for 17 consecutive days and
then only vehicle for an additional 7 d. The second group (n = 6) received only vehicle injections over the
same number of days. CX516 improved performance within sessions,
particularly on trials with delays of 6-35 sec. In 9 of 12 rats, the
positive effect of the drug was also present on nondrug days between
CX516 administration and after cessation of CX516 injections. The
animals that received only vehicle injections showed no improvement in DNMS performance over the entire 32 d of testing. Three of the 12 animals given CX516 did not exhibit "carryover" effects of the drug
to the intervening (vehicle only) test sessions, but nonetheless
exhibited superior performance during the first half of the session on
days in which the ampakine was administered. Evaluation of errors
suggests that the ampakine eliminated the necessity for a shift
in response strategy that produced proactive interference on the
following trial. Hippocampal involvement in these ampakine effects is
discussed as a prelude to the second article in the series ().
Key words:
ampakine; hippocampus; learning; memory; behavior; delay-dependent memory; proactive interference
Copyright © 1998 Society for Neuroscience 0270-6474/98/1872740-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. Ogier, H. Wang, E. Hong, Q. Wang, M. E. Greenberg, and D. M. Katz
Brain-Derived Neurotrophic Factor Expression and Respiratory Function Improve after Ampakine Treatment in a Mouse Model of Rett Syndrome
J. Neurosci.,
October 3, 2007;
27(40):
10912 - 10917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gray and B. L. Roth
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Schizophr Bull,
September 1, 2007;
33(5):
1100 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bespalov, A.-L. Jongen-Relo, M. van Gaalen, S. Harich, H. Schoemaker, and G. Gross
Habituation Deficits Induced by Metabotropic Glutamate Receptors 2/3 Receptor Blockade in Mice: Reversal by Antipsychotic Drugs
J. Pharmacol. Exp. Ther.,
February 1, 2007;
320(2):
944 - 950.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Rex, J. C. Lauterborn, C.-Y. Lin, E. A. Kramar, G. A. Rogers, C. M. Gall, and G. Lynch
Restoration of Long-Term Potentiation in Middle-Aged Hippocampus After Induction of Brain-Derived Neurotrophic Factor
J Neurophysiol,
August 1, 2006;
96(2):
677 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Ramsey, M. M. Adams, O. J. Ariwodola, W. E. Sonntag, and J. L. Weiner
Functional Characterization of Des-IGF-1 Action at Excitatory Synapses in the CA1 Region of Rat Hippocampus
J Neurophysiol,
July 1, 2005;
94(1):
247 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. K. Murray, K. Whalley, C. S. Robinson, M. A. Ward, C. A. Hicks, D. Lodge, J. L. Vandergriff, P. Baumbarger, E. Siuda, M. Gates, et al.
LY503430, a Novel {alpha}-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Potentiator with Functional, Neuroprotective and Neurotrophic Effects in Rodent Models of Parkinson's Disease
J. Pharmacol. Exp. Ther.,
August 1, 2003;
306(2):
752 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Matzel, Y. R. Han, H. Grossman, M. S. Karnik, D. Patel, N. Scott, S. M. Specht, and C. C. Gandhi
Individual Differences in the Expression of a "General" Learning Ability in Mice
J. Neurosci.,
July 23, 2003;
23(16):
6423 - 6433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Fillit, R. N. Butler, A. W. O'Connell, M. S. Albert, J. E. Birren, C. W. Cotman, W. T. Greenough, P. E. Gold, A. F. Kramer, L. H. Kuller, et al.
Achieving and Maintaining Cognitive Vitality With Aging
Mayo Clin. Proc.,
July 1, 2002;
77(7):
681 - 696.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Baumbarger, M. Muhlhauser, J. Zhai, C. R. Yang, and E. S. Nisenbaum
Positive Modulation of alpha -Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) Receptors in Prefrontal Cortical Pyramidal Neurons by a Novel Allosteric Potentiator
J. Pharmacol. Exp. Ther.,
July 1, 2001;
298(1):
86 - 102.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. C. Lauterborn, G. Lynch, P. Vanderklish, A. Arai, and C. M. Gall
Positive Modulation of AMPA Receptors Increases Neurotrophin Expression by Hippocampal and Cortical Neurons
J. Neurosci.,
January 1, 2000;
20(1):
8 - 21.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Hampson, L. E. Jarrard, and S. A. Deadwyler
Effects of Ibotenate Hippocampal and Extrahippocampal Destruction on Delayed-Match and -Nonmatch-to-Sample Behavior in Rats
J. Neurosci.,
February 15, 1999;
19(4):
1492 - 1507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Hampson, G. Rogers, G. Lynch, and S. A. Deadwyler
Facilitative Effects of the Ampakine CX516 on Short-Term Memory in Rats: Correlations with Hippocampal Neuronal Activity
J. Neurosci.,
April 1, 1998;
18(7):
2748 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|